Beyond Punishment: Reforming India's Drug Policy Through Harm Reduction
As India grapples with new trafficking routes and technologies, a debate is intensifying over its punitive drug laws and the need for a public health-centric approach focused on harm reduction and rehabilitation.
What is the core tension in India's drug policy?
The central conflict in India's narcotics approach is the dominance of a criminal justice framework over a public health one. The NDPS Act, 1985, primarily treats drug use as a crime, a stance rooted in Article 47 of the Constitution, which directs the state to prohibit intoxicating substances. The law does not differentiate between a casual user, a dependent person, or a trafficker in its definition of possession. For instance, under Section 27, possession of a 'small quantity' of heroin can result in imprisonment for up to one year (Source: The Hindu). This punitive stance has led to a policy focus on arrests and seizures as primary metrics of success. This approach faces internal challenges, with the Ministry of Social Justice and Empowerment itself recommending in 2022 that the Department of Revenue decriminalise personal consumption of small quantities (Source: The Indian Express).
What are the emerging challenges to drug enforcement?
India's geography places it between the 'Golden Crescent' (Afghanistan, Pakistan, Iran) and the 'Golden Triangle' (Myanmar, Thailand, Laos), two major opium-producing regions. According to the International Narcotics Control Board, Myanmar has surpassed Afghanistan as the world's leading source of illicit opium, a development of concern given its porous border with India's northeastern states (Source: The Hindu). Enforcement agencies face new trafficking dynamics. The NCB has noted a significant increase in the use of drones to smuggle drugs across the Punjab border. Concurrently, maritime routes are increasingly used to deliver narcotics to coastal states like Gujarat and Kerala. Traffickers also leverage technology, organising on the darknet and using cryptocurrencies, which complicates tracing. A major domestic challenge is the diversion of pharmaceutical ingredients for synthetic drugs, an issue where regulatory penalties for producers are often less severe than those for individuals caught with small quantities of the final product.
Keep reading this explainer
This is the opening of a 1457-word explainer. An account brings you the rest, a PDF to keep and the whole Explained archive.
Takes about a minute. Your email and a password is all it needs.